Tysuna®

Sunitinib

Product Information

  • Proprietary Name: Tysuna®
  • Generic Name: Sunitinib
  • Dosage Form: Hard Gelatin Capsule
  • Strengths: 12.5 mg, 25 mg, 50 mg
  • Indications: Gastrointestinal Stromal Tumor, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumors

Oncology

Tysuna®

Sunitinib is indicated for the treatment of gastrointestinal stromal tumor, renal cell carcinoma, and pancreatic neuroendocrine tumors.

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.